1-4 of 4
José Luís García de Veas Silva
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immunoglobulin Heavy/Light Chain Ratio and Suppression of the Myeloma Non-Involved Heavy/Light Chain Pair Isotype Correlate with Poor Survival in Multiple Myeloma at Diagnosis and after Autologous Stem Cell Transplant

José Luís García de Veas Silva, Nuno Barbosa, Rafael Rios Tamayo, Carmen Bermudo Guitarte, Tiago M Pais, PhD, Teresa Rodríguez Ruiz
Journal: Blood
Blood (2016) 128 (22): 5647.
https://doi.org/10.1182/blood.V128.22.5647.5647
Published: 2016
Journal Articles

Multiple Myeloma with Prior Precursor Disease Shows Better Outcome

Rafael Ríos-Tamayo, MD, Juan Sáinz Pérez, Manuel Jurado, MD, Jose Manuel Puerta Puerta, MD, Pedro Antonio González Sierra, MD, Antonio Romero Aguilar, MD, Elisa Lopez Fernandez, MD, Lucia Moratalla Lopez, MD, José Luís García de Veas Silva, Teresa Rodríguez Ruiz, José Juan Jiménez Moleón, MD, María José Sánchez Pérez, MD
Journal: Blood
Blood (2015) 126 (23): 1756.
https://doi.org/10.1182/blood.V126.23.1756.1756
Published: 2015
Journal Articles

A New Model for Risk Stratification in Patients with Newly Diagnosed Multiple Myeloma: Impact of Serum Free Light Chains in Prognosis

José Luís García de Veas Silva, Johanna Carolina Rojas Novoa, Carmen Bermudo Guitarte, Stephen Harding, PhD, Luisa Campos, Rafael Duro Millan
Journal: Blood
Blood (2015) 126 (23): 5338.
https://doi.org/10.1182/blood.V126.23.5338.5338
Published: 2015
Journal Articles

Value Of Serum Free Light Chains Ratio As New Biomarker Of High Prognostic Value In Patients With Newly Diagnosed Multiple Myeloma

José Luis García de Veas Silva, Carmen Bermudo, Stephen Harding, Rafael Duro Millán
Journal: Blood
Blood (2013) 122 (21): 1862.
https://doi.org/10.1182/blood.V122.21.1862.1862
Published: 2013